Riskpilot← Back to searchSign inGet full accessDele Health Tech AB
ABIn liquidationOrg 5592695919FalunComputer programming activities · NACE 6201Est. 20201 employees
Revenue 2023
SEK 135K
-74% vs 2022
EBITDA margin
-751.5%
+78% vs 2022
Equity ratio
-3.0%
Financial strength
Net profit 2023
SEK -1M
+78% vs 2022
| Revenue | SEK 135K | -74% |
| EBITDA | SEK -1M | +78% |
| Net profit | SEK -1M | +78% |
| Total assets | SEK 165K | -97% |
| Equity | SEK -5K | -120% |
| Employees | 1 | — |
Legal name
Dele Health Tech AB
Org number
5592695919
Legal form
Aktiebolag
NACE code
6201 · Computer programming activities
Founded
2 september 2020
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av likvidatorn externa firmatecknarna
Company purpose
Företagets syfte är programvaruarkitektur och utveckling, samt konsulttjänster inom medicinska applikationer för webb- och mobilplattformar, investeringar i relaterade företag och konsulttjänster avseende investeringar i forskning och miljörelaterade affärsområden.
Address
Falun
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 |
|---|---|---|---|
| Revenue | 0 | 529 | 135 |
| Staff expenses | — | −4 233 | −802 |
| EBITDA | −5 433 | −4 685 | −1 015 |
| Depreciation & amort. | −0 | — | — |
| EBIT | −5 433 | −4 685 | −1 015 |
| Net financials | −1 | −2 | −3 |
| Profit before tax | −5 434 | −4 687 | −1 018 |
| Tax | −0 | — | — |
| Net profit | −5 434 | −4 687 | −1 018 |
| Item | 2021 | 2022 | 2023 |
|---|---|---|---|
| Total assets | 993 | 6 091 | 165 |
| Equity | 25 | 25 | −5 |
| Long-term debt | 315 | 5 494 | 85 |
| Short-term debt | 653 | 572 | 85 |
| Total debt | 968 | 6 066 | 170 |
EBITDA margin
-751.5%
This company
15.8%
Market median
-4856% vs market
20212023
Equity ratio
-3.0%
This company
38.2%
Market median
-108% vs market
20212023
Return on equity
-101788800.0%
This company
18.4%
Market median
-553200100% vs market
20212023
Net profit margin
-754.0%
This company
8.1%
Market median
-9409% vs market
20212023
Asset turnover
0.82×
This company
1.12×
Market median
+27% vs market
20212023
Debt / equity
34.10×
This company
0.62×
Market median
-5400% vs market
20212023
| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
LB External Signatory | External Signatory | 2024 |
IM External Signatory | External Signatory | 2024 |
BJ External Signatory | External Signatory | 2024 |
KO Liquidator | Liquidator | 2024 |
UM External Signatory | External Signatory | 2024 |
| Former (3) | ||
PM Chief Executive Officer | Chief Executive Officer | 2021 – 2022 |
BA Chief Executive Officer | Chief Executive Officer | 2021 – 2022 |
PE Chief Executive Officer | Chief Executive Officer | 2022 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Former (4) | ||
| Board of Directors | 2021 – 2022 | |
| Board of Directors | 2021 – 2024 | |
| Chairman | 2022 – 2024 | |
| Chairman | 2021 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Dele Health Tech AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lena Birgitta Killgren Jonsson | External Signatory | 0 companies |
| Inger Margareta Dahle | External Signatory | 0 companies |
| Peter Martin Liljander | Chief Executive Officer | 0 companies |
| Bo Arne Lennart Hallberg | Chief Executive Officer | 0 companies |
| Bengt Junior Niklas Nygårds | External Signatory | 0 companies |
| Knut Olof Mikael Rosén | Liquidator | 0 companies |
| Ulrika Margareta Ahlholm | External Signatory | 0 companies |
| Per Erik Anders Jakobsson | Chief Executive Officer | 0 companies |
| John Patrik Johansson | Board of Directors | 0 companies |
| Øyvind Sæta | Board of Directors | 0 companies |
| Susan Elizabeth Hagerty Bonsak | Chairman | 0 companies |
| Carine Zeier | Chairman | 0 companies |